EFFICACY RESULTS OF 0.2.G/DAY FLUOCINOLONE ACETONIDE IMPLANT (FAC) IN DMO VITRECTOMISED PATIENTS

被引：0
|
作者：
Erginay, A. [1 ]
Habib, M. [2 ]
Goldsmith, C. [3 ]
Schmit-Eilenberger, V. [4 ]
Massin, P. [1 ,5 ]
机构：
[1] Lariboisiere Univ Hosp, AP HP, Paris, France
[2] Sunderland Eye Hosp, Sunderland, Tyne & Wear, England
[3] James Paget Univ Hosp, Great Yarmouth, Norfolk, England
[4] Karlsruhe Eye Clin, Karlsruhe, Germany
[5] Opthalm Clin Breteuil, Paris, France
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2016年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E109 / E110
页数：2
相关论文
共 50 条
  • [1] ASSESSMENT OF COST-EFFECTIVENESS OF A 0.2 MCG/DAY FLUOCINOLONE ACETONIDE (FAC) IMPLANT IN PATIENTS WITH CHRONIC DIABETIC MACULAR OEDEMA (DMO) IN AN EYE WITH CATARACT
    Beiderbeck, A.
    Aballea, S.
    Pochopien, M.
    Bellier, L.
    Toumi, M.
    VALUE IN HEALTH, 2019, 22 : S574 - S574
  • [2] Optimization of diabetic macular edema (DME) therapy following 0.2 μg/day fluocinolone acetonide (FAc) implant administration
    Gonzalez, Victor H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [3] Clinical effectiveness of the fluocinolone acetonide (FAc) implant in patients with diabetic macular oedema (DMO) - the Manchester experience.
    Walkden, Andrew
    Young, James
    Stone, Amy
    Mahmood, Sajjad
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [4] Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy
    Meireles, A.
    Goldsmith, C.
    El-Ghrably, I.
    Erginay, A.
    Habib, M.
    Pessoa, B.
    Coelho, J.
    Patel, T.
    Tadayoni, R.
    Massin, P.
    Atorf, J.
    Augustin, A. J.
    EYE, 2017, 31 (05) : 684 - 690
  • [5] Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy
    A Meireles
    C Goldsmith
    I El-Ghrably
    A Erginay
    M Habib
    B Pessoa
    J Coelho
    T Patel
    R Tadayoni
    P Massin
    J Atorf
    A J Augustin
    Eye, 2017, 31 : 684 - 690
  • [6] Discontinuous to Continuous Therapy with 0.2 μg/day Fluocinolone Acetonide implant (FAc) Leads to Reduction in Treatment Frequency for Diabetic Macular Edema (DME)
    Adams, Olufemi E.
    Schechet, Sidney
    Hariprasad, Seenu
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [7] The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis
    Biswas, Jyotirmay
    Tyagi, Mudit
    Agarwal, Manisha
    OPHTHALMOLOGY SCIENCE, 2024, 4 (01):
  • [8] The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema
    Alexander Eaton
    Sean S. Koh
    Jaime Jimenez
    Christopher D. Riemann
    Ophthalmology and Therapy, 2019, 8 : 51 - 62
  • [9] The USER Study: A Chart Review of Patients Receiving a 0.2μg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema
    Eaton, Alexander
    Koh, Sean S.
    Jimenez, Jaime
    Riemann, Christopher D.
    OPHTHALMOLOGY AND THERAPY, 2019, 8 (01) : 51 - 62
  • [10] Fluocinolone acetonide ( FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME)
    Liu, John
    Coney, Joseph
    Schartman, Jerome
    Miller, David G.
    Zegarra, Hernando
    Rao, Llewelyn
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
12345